ArticleDiscover oncology2026

The effect of resiquimod (a Toll-like receptor-7/8 agonist) on the balance between pro-inflammatory and anti-inflammatory cytokines in breast cancer patients.

Eman ElAlfy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.